Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: G6780B33D818EN
QYResearch

Abstracts

Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• Roche
• Regeneron Pharmaceuticals
• Bayer
• Santen Oy
• Kanghong Pharmaceuticals
• Novartis
• Eli Lilly and Company
• TRACON Pharmaceuticals
• Pfizer
• GSK
• BIOCAD

Market segment by Type, the product can be split into

• Agonist
• Allosteric Modulator
• Kinase Inhibitor
• Monoclonal Antibody
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue
1.4 Market by Type
  1.4.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Agonist
  1.4.3 Allosteric Modulator
  1.4.4 Kinase Inhibitor
  1.4.5 Monoclonal Antibody
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Perspective (2015-2026)
2.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Growth Trends by Regions
  2.2.1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players by Market Size
  3.1.1 Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players by Revenue (2015-2020)
  3.1.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Concentration Ratio
  3.2.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2019
3.3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players Head office and Area Served
3.4 Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Solution and Service
3.5 Date of Enter into Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Historic Market Size by Type (2015-2020)
4.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)
5.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2015-2020)
6.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players in North America (2019-2020)
6.3 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020)
6.4 North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2015-2020)
7.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players in Europe (2019-2020)
7.3 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020)
7.4 Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2015-2020)
8.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players in China (2019-2020)
8.3 China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020)
8.4 China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2015-2020)
9.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players in Japan (2019-2020)
9.3 Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020)
9.4 Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2015-2020)
10.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2015-2020)
11.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players in India (2019-2020)
11.3 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020)
11.4 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size (2015-2020)
12.2 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020)
12.4 Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview
  13.1.3 Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.1.4 Roche Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Regeneron Pharmaceuticals
  13.2.1 Regeneron Pharmaceuticals Company Details
  13.2.2 Regeneron Pharmaceuticals Business Overview
  13.2.3 Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.2.4 Regeneron Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.2.5 Regeneron Pharmaceuticals Recent Development
13.3 Bayer
  13.3.1 Bayer Company Details
  13.3.2 Bayer Business Overview
  13.3.3 Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.3.4 Bayer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.3.5 Bayer Recent Development
13.4 Santen Oy
  13.4.1 Santen Oy Company Details
  13.4.2 Santen Oy Business Overview
  13.4.3 Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.4.4 Santen Oy Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.4.5 Santen Oy Recent Development
13.5 Kanghong Pharmaceuticals
  13.5.1 Kanghong Pharmaceuticals Company Details
  13.5.2 Kanghong Pharmaceuticals Business Overview
  13.5.3 Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.5.4 Kanghong Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.5.5 Kanghong Pharmaceuticals Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview
  13.6.3 Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.6.4 Novartis Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 Eli Lilly and Company
  13.7.1 Eli Lilly and Company Company Details
  13.7.2 Eli Lilly and Company Business Overview
  13.7.3 Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.7.4 Eli Lilly and Company Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.7.5 Eli Lilly and Company Recent Development
13.8 TRACON Pharmaceuticals
  13.8.1 TRACON Pharmaceuticals Company Details
  13.8.2 TRACON Pharmaceuticals Business Overview
  13.8.3 TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.8.4 TRACON Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.8.5 TRACON Pharmaceuticals Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview
  13.9.3 Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.9.4 Pfizer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.9.5 Pfizer Recent Development
13.10 GSK
  13.10.1 GSK Company Details
  13.10.2 GSK Business Overview
  13.10.3 GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  13.10.4 GSK Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  13.10.5 GSK Recent Development
13.11 BIOCAD
  10.11.1 BIOCAD Company Details
  10.11.2 BIOCAD Business Overview
  10.11.3 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Introduction
  10.11.4 BIOCAD Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020)
  10.11.5 BIOCAD Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue
Table 3. Ranking of Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Agonist
Table 6. Key Players of Allosteric Modulator
Table 7. Key Players of Kinase Inhibitor
Table 8. Key Players of Monoclonal Antibody
Table 9. Key Players of Others
Table 10. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Regions (2015-2020)
Table 14. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players
Table 21. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Players (2015-2020)
Table 23. Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs as of 2019)
Table 24. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Solution and Service
Table 27. Date of Enter into Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Type (2015-2020)
Table 31. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Application (2015-2020)
Table 33. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share (2019-2020)
Table 37. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2015-2020)
Table 39. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share (2019-2020)
Table 43. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2015-2020)
Table 45. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2015-2020)
Table 47. China Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share (2019-2020)
Table 49. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2015-2020)
Table 51. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share (2019-2020)
Table 55. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2015-2020)
Table 57. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share (2019-2020)
Table 61. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2015-2020)
Table 65. India Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share (2019-2020)
Table 67. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2015-2020)
Table 69. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share (2019-2020)
Table 73. Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type (2015-2020)
Table 75. Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application (2015-2020)
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Product
Table 80. Roche Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 81. Roche Recent Development
Table 82. Regeneron Pharmaceuticals Company Details
Table 83. Regeneron Pharmaceuticals Business Overview
Table 84. Regeneron Pharmaceuticals Product
Table 85. Regeneron Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 86. Regeneron Pharmaceuticals Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Product
Table 90. Bayer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 91. Bayer Recent Development
Table 92. Santen Oy Company Details
Table 93. Santen Oy Business Overview
Table 94. Santen Oy Product
Table 95. Santen Oy Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 96. Santen Oy Recent Development
Table 97. Kanghong Pharmaceuticals Company Details
Table 98. Kanghong Pharmaceuticals Business Overview
Table 99. Kanghong Pharmaceuticals Product
Table 100. Kanghong Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 101. Kanghong Pharmaceuticals Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Product
Table 105. Novartis Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 106. Novartis Recent Development
Table 107. Eli Lilly and Company Company Details
Table 108. Eli Lilly and Company Business Overview
Table 109. Eli Lilly and Company Product
Table 110. Eli Lilly and Company Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 111. Eli Lilly and Company Recent Development
Table 112. TRACON Pharmaceuticals Business Overview
Table 113. TRACON Pharmaceuticals Product
Table 114. TRACON Pharmaceuticals Company Details
Table 115. TRACON Pharmaceuticals Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 116. TRACON Pharmaceuticals Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Product
Table 120. Pfizer Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 121. Pfizer Recent Development
Table 122. GSK Company Details
Table 123. GSK Business Overview
Table 124. GSK Product
Table 125. GSK Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 126. GSK Recent Development
Table 127. BIOCAD Company Details
Table 128. BIOCAD Business Overview
Table 129. BIOCAD Product
Table 130. BIOCAD Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business (2015-2020) (Million US$)
Table 131. BIOCAD Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Type: 2020 VS 2026
Figure 2. Agonist Features
Figure 3. Allosteric Modulator Features
Figure 4. Kinase Inhibitor Features
Figure 5. Monoclonal Antibody Features
Figure 6. Others Features
Figure 7. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Report Years Considered
Figure 12. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Players in 2019
Figure 17. Global Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2019
Figure 19. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed